Increasing levels of estrogen and progesterone are suggested to play a role in the gender switch in 31 asthma prevalence during puberty. We investigated whether the process of sexual maturation in 32 mice affects the development of lung inflammation in adulthood and the contributing roles of 33 estrogen and progesterone during this process. 34
Introduction

49
Asthma prevalence is higher in boys than in girls during early childhood (1, 2, 3, 4) . At the onset of 50 puberty, however, this sex difference reverses (11, 13, 20, 48, 60) . Adult asthma is not only more 51 common in women, but asthma is also more severe in women than men (27, 48, 52, 62). Female sex 52 hormones, i.e. estrogen and progesterone, have been linked to the higher risk of girls to develop 53 asthma during puberty, when hormone levels increase (7). Girls with an earlier menarche have a 54
higher risk of developing asthma, which may be explained by exposure to greater cumulative 55 estrogen and progesterone levels than girls with late menarche (25, 28, 46, 58) . These studies clearly 56 suggest a role of estrogen and progesterone in asthma development and severity, yet experimental 57 findings are anything but clear. 58
Some studies report worsening of asthma in women when estrogen and progesterone levels are 59 high, and others that low hormone levels coincide with worse asthma symptoms (6, 14, 16, 29, 30, 60 39, 40, 43). Contradictory results were also found in animal studies using mice and rats. Both pro-61 inflammatory and anti-inflammatory effects of estrogen and progesterone have been reported in 62 mouse and rat models of asthma with a variety of explanations for these conflicting results (8, 18, 26, 63 35, 37, 38, 44). However, little is known about how puberty per se affects asthma development later 64 in life and how the changes in either estrogen or progesterone levels during puberty affect asthma 65
development. 66
This is of interest as estrogen can have direct effects on the immune system by binding to estrogen 67 receptors expressed by several immune cells (10). Additionally, estrogen can influence airway 68 responses indirectly by acting on structural cells, such as airway epithelial cells. In response to 69 inhaled allergen, airway epithelial cells induce nuclear factor (NF)-B-signaling and subsequently 70 recruit and activate immune cells through production of pro-asthmatic mediators such as IL-33 and 71 TSLP (17, 23). To protect the airways against escalating inflammation and subsequent damage, 72 epithelial cells also secrete anti-inflammatory factors such as secretory leukoprotease inhibitor (SLPI) 73 (31). SLPI exerts its anti-inflammatory effects via inhibition of NF-B-signaling. Interestingly, SLPI 74 expression has been found to be upregulated by estrogen treatment (9, 54, 55), but has not been 75 linked to IL-33 signaling yet. 76 We investigated the development of allergic lung inflammation subsequent to ovalbumin challenge 77 in adult female mice that did not go through puberty and assessed whether the increase in estrogen 78 or progesterone levels during puberty affect the severity of allergic lung inflammation in female adult 79 mice. Our studies showed that going through puberty actually leads to less severe lung inflammation 80 in adult female mice as compared to mice going through puberty. In addition, we also found that 81 allergic lung inflammation is inhibited by a sole increase in estrogen during puberty, but was not 82 affected by a sole increase in progesterone during puberty. This inhibition is associated with higher 83
SLPI expression that appears to inhibit the production of the pro-inflammatory cytokine IL-33. 84
85
Materials and methods 86
Animals 87
Female BALB/c mice (aged 3 weeks) were obtained from Harlan (Horst, The Netherlands). The mice 88
were fed ad libitum with standard food and water and were kept in a temperature and light-89 controlled room (lights on from 7.30 am until 7.30 pm). Animal procedures were approved by the 90
Institutional Animal Care and Use Committee of the University of Groningen (application number 91 4609) and were performed under strict governmental and international guidelines. All surgeries were 92 performed under isoflurane/oxygen anesthesia and all efforts were made to minimize suffering 93 including the use of buprenorphine for pain management after surgery. 94
95
Ovariectomy and OVA model 96
Female BALB/c mice were ovariectomized (OVX) or sham-treated (SHAM) at 28 days of age before 97 reaching sexual maturity (around day 35). OVX animals were either left untreated or subcutaneously 98 received a 60-day slow release pellet of 0.1 mg estrogen (OVX+E2) or 15 mg progesterone (OVX+P) 99 (IRA, Sarasota, FL, USA) at the time of ovariectomy. These E2 and P pellets were chosen because they 100 have been shown to yield plasma levels about two times higher (E2 ±350 pg/ml, P ±55 ng/ml) than 101 levels at estrus (for E2 ±150 pg/ml and for P ±25 ng/ml) (50). Uterine weight was assessed to check to 102 quality of ovariectomy, estrogen and progesterone treatment (see figure S1 of the supplemental 103 data). Ovariectomy strongly reduced uterine weight as compared to sham treatment. Estrogen 104 treatment mostly prevented this low uterine weight, and progesterone treatment led to slightly, but 105 significantly, higher uterine weight as compared to ovariectomy. Animals with normal (>40 mg) 106 uterine weights after ovariectomy were excluded from the studies, as were animals with low (<15 107 mg) uterine weights after estrogen (indicating the pellet did not work) and or high (>50 mg) uterine 108 weights after progesterone treatment (indicating that ovariectomy was not performed successfully). 109
Four weeks after ovariectomy (age 8 weeks), mice were sensitized intraperitoneally to 10 g of 110 ovalbumin (OVA, Grade V, Sigma-Aldrich Chemie BV, Zwijndrecht, The Netherlands) and 1.5 mg of 111 alum (Aluminject, Pierce Chemical, Etten-Leur, The Netherlands) on days 1 and 7, followed on day 112 14-20 by daily 20-min aerosol challenges with 1% w/v OVA in sterile PBS using a Pari LC Sprint Star 113 nebulizer driven by a PARI Boy SX compressor (both kind gifts from Pari GmbH, Starnberg, Germany). 114
Healthy controls (n=8) were not sensitized with alum and were exposed to PBS. An overview of the 115 experimental design is depicted in figure 1 . 116
On day 21 (age 11 weeks), serum was collected for OVA-specific IgE and animals were either 117 sacrificed to collect bronchoalveolar lavage fluid and to isolate lung cells from digested lung for flow 118 cytometry or sacrificed for histological analyses of lung tissue. The experimental groups consisted of 119 32 SHAM mice (15 for lavage/flow and 17 for histology), 18 OVX mice (10 for lavage/flow and 8 for 120 histology), 11 OVX+E2 mice (6 for lavage/flow and 5 for histology), and 14 OVX+P (6 for lavage/flow 121 and 8 for histology). 122
123
OVA-specific IgE 124
Serum levels of OVA-specific IgE were measured by ELISA as described previously (33) . OVA-specific 125
IgE titers are expressed as arbitrary ELISA units that were interpolated from a standard curve of a 126 reference serum. 127
128
Bronchoalveolar lavage fluid 129
Bronchoalveolar lavage fluid was collected and cells were processed for cytospots to determine the 130 percentage of eosinophils as described previously (33) . Total and differential cell counts can be found 131 in table S2 of the supplemental data. Lavage supernatants were used to assess the levels of secretory 132 leucocyte protease inhibitor (SLPI) and IL-33. 133 SLPI levels in lavage supernatants were determined by western blot analysis using a biotinylated goat 134 polyclonal α-SLPI antibody (R&D Systems, Oxon, UK). Briefly, equal amounts of total protein (25 µg) 135
were run on a 15% SDS-PAGE gel and subsequently transferred to polyvinylidene difluoride 136 membranes (Roche, Mannheim, Germany). The membranes were blocked with 5% blotting grade 137 non-fat milk (Biorad, Veenendaal, Netherlands) and incubated with an anti-SLPI antibody overnight 138 (in 5% milk). Next, the blots were incubated with rabbit-anti-goat HRP-conjugated secondary 139 antibody followed by a goat-anti-rabbit HRP-conjugated tertiary antibody (both DAKO, Glostrup, 140 Denmark). Blots were subsequently developed using sensitive Western Lightning-ECL reagent 141 (Perkin-Elmer, Boston, MA) in a G-Box (Syngene, Cambridge, U.K.). Molecular weights were 142 estimated based on the migration of ten known molecular weight standards (Biorad, Veenendaal, 143
The Netherlands). Digital evaluation of blots was performed by GeneTools analysis software 144 (Syngene, Cambridge, U.K.), which assigns a peak height to each band. The relative SLPI expression is 145 described as SLPI expression in lavage fluid of OVX and OVX+E2 mice in relation to the SLPI 146 expression in lavage fluid of SHAM mice. 147
The levels of IL-33 in lavage supernatants were determined by ELISA kits according to the 148 manufacturer's instructions (R&D Systems). 149
150
Lung digestion 151
After bronchoalveolar lavage, lungs were minced and incubated in RPMI medium supplemented with 152 10% fetal calf serum (both Lonza, Verviers, Belgium), 10 μg/ml DNAse I (grade II from bovine 153 pancreas, Roche Applied Science, Almere, Netherlands), and 0.7 mg/ml collagenase A (Sigma-Aldrich) 154
for 45 min at 37°C in a shaking water bath. Single cell suspensions of lungs were obtained by passing 155 the digested lung tissue through a 70 μm nylon strainer (BD Biosciences, Breda, Netherlands). 156
Contaminating erythrocytes were lyzed using 10 times diluted Pharmlyse (BD Biosciences). 157
Mononuclear cells were then enriched by performing discontinuous Percoll (Pharmacia, Uppsala, 158 Sweden) gradient centrifugation (20 to 55%). Cells collected on the 55% and 45% layers were passed 159 through a 35 μm nylon strainer (BD Biosciences) and counted using a Sysmex pocH-100i cell counter 160 (Sysmex, Roche, Germany). Total cell counts can be found in table S3 of the supplemental data. figure 3A-D) . Higher levels of OVA-specific IgE levels were found in 249 OVA-exposed SHAM-treated mice as compared to healthy controls. OVA-specific IgE levels in serum 250
were not significantly affected by ovariectomy, but treating ovariectomized mice with estrogen also 251 led to significantly lower levels as compared to untreated ovariectomized mice. Ovariectomized + 252 progesterone-treated mice and untreated ovariectomized mice had similar levels of OVA-specific IgE 253 The SLPI levels we determined in lavage fluid of control mice were too low to be detected but these 269 levels increased significantly in mice subjected to OVA-induced lung inflammation ( figure 5A and B) . 270
Ablating estrogen before sexual maturity led to lower SLPI levels in lavage fluid of ovariectomized 271 mice as compared to sham-treated mice. Subsequently treating ovariectomized mice with estrogen 272 restored higher SLPI levels as compared to untreated ovariectomized mice. We also tried to assess IL-273 33 in lavage fluid, but found no detectable levels (data not shown). 
Discussion
297
Before puberty more boys suffer from asthma than girls, while this distribution changes during 298 puberty and more females develop asthma after puberty and suffer from more severe disease as 299 compared to males (1, 2, 13, 20, 27, 48, 60) . Although many studies have focused on the female sex 300 hormones estrogen and progesterone to explain this dichotomy, their roles remain inconclusive. We 301 found that preventing sexual maturation by ablating sex hormones before "puberty" in mice 302
significantly increased the number of eosinophils and B lymphocytes as compared to sham-treated 303 mice, suggesting that the process of sexual maturation actually ameliorates some aspects of 304 subsequent lung inflammation in adult mice. Interestingly, this beneficial effect of sexual maturation 305 appears to solely depend on estrogen, as estrogen but not progesterone substitution after 306 ovariectomy inhibited lung inflammation. This effect of estrogen is associated with higher production 307 of SLPI and lower production of IL-33 by cells in lung parenchyma. Our further findings showed that 308 SLPI could directly inhibit IL-33 production in alveolar epithelial cells explaining how estrogen may 309 play a protective role in the development of lung inflammation. 310 Similar as seen in humans, female mice develop more severe allergic lung inflammation than male 311 mice and therefore this model was used to study effects of sexual maturation and sex hormones in 312 asthma development (34). Contrary to our findings, previous studies on rat and mouse ovalbumin-313 induced allergic airway inflammation have shown that depletion of sex hormones before 314 sensitization inhibits lung inflammation and that treatment with estrogen before and during 315 ovalbumin immunization re-established lung inflammation in these ovariectomized animals (26, 37, 316 44). In addition, both pro-and anti-inflammatory effects of progesterone on asthma development 317 have been described (18, 35, 37) . These previous studies have in common that ovariectomy or 318 hormone treatments were performed in adult animals with different timings of 319 ovariectomy/treatment with respect to induction of lung inflammation, which may be an important 320 determinant in the outcome of those studies. Since we focused on the relationship between 321 increasing estrogen and progesterone levels during puberty and the development of lung 322 inflammation, we performed ovariectomy and started estrogen or progesterone treatment before 323 sexual maturation and induced lung inflammation in adulthood. Contrary to our expectations, our 324 data clearly showed that the hormone-driven process of sexual maturation ameliorates some aspects 325 of the development of lung inflammation in adulthood. The disparity with the clinical situation may 326 be explained by the observational nature of the clinical studies and the fact that sexual maturation in 327 humans is a multi-factorial process that involves more than just an elevation of and the start of 328 cycling of sex hormones. 329
An explanation for the protective effect of hormone-driven sexual maturation may be found in the 330 changes in expression of immune genes that was shown to occur during sexual maturation in mice 331 (22). Lamason et al. showed a sexual dimorphism in innate and adaptive immune functions in post-332 pubertal mice, which was dependent on puberty. Female mice had higher expression of adaptive 333 immune genes while males had higher expression of innate immune genes after sexual maturation. 334
The ovariectomy that we performed before this "puberty"-induced difference in immune function 335 could occur, may have prevented the upregulation of genes of the adaptive immune system and 336 thereby make female mice more susceptible to allergic lung inflammation. Here we did not study the 337 expression of immune genes, but it would be interesting to know what happens after substitution of 338 estrogen and progesterone, even though this would be without the natural cycling changes in sex 339 hormone levels. Both hormones were given at levels exceeding estrus levels (E2: ±150 pg/ml, P:±25 340 ng/ml) around a factor of 2 (E2: ±350 pg/ml, P:±55 ng/ml) (50). In sexually mature animals these 341 levels have been shown to promote lung inflammation and T helper 2 responses when exposed to 342 allergens, and also to induce regulatory T cells in healthy animals (18, 35, 36, 56, 57) . However, in our 343 case estrogen substitution after ovariectomy strongly inhibited lung inflammation and this was 344 accompanied with lower numbers of regulatory T cells, while progesterone substitution had no effect 345 at all as compared to untreated ovariectomy. It therefore seems likely that estrogen substitution 346 induces changes in immune gene expression or immune function that is still possible in sexually 347 immature animals but can no longer occur in animals that have gone through normal sexual 348 maturation. The fact that normal sexual maturation only moderately protects against lung 349 inflammation as compared to the strong protection of estrogen substitution, may be explained by 350 the lack of corresponding progesterone increases in our model. The increasing levels of progesterone 351 may counteract the effects of estrogen during normal development. The importance of the ratio of 352 circulating estrogen-to-progesterone levels in the response to allergens was recently also suggested 353 by others (37, 57). 354
To elucidate the mechanism behind the estrogen-mediated protective effects on lung inflammation, 355 we first focused on quantifying known pro-asthmatic mediators like TSLP and IL-33. Our previous 356 studies in males and females did not show differences in TSLP (32), so we decided to study IL-33 first. that it is a key mediator in asthma (19). In response to extracellular ATP, IL-33 expression was higher 388 in AECII cells, but the production was significantly lower when SLPI was added. These findings 389 confirm the anti-inflammatory effects of SLPI as described previously in monocytes (12). Exogenously 390 applied SLPI to monocytes is taken up into the cells and is distributed in the cytoplasm and nucleus. 391
There it blocks NF-B activation by inhibiting the degradation of IBa and IBb and by competing 392 with p65 for binding to NF-κB sites in the promoters of NF-κB-responsive genes and inhibits the 393 production of pro-inflammatory cytokines (15, 54, 55). 394
Taken together, our data show that the sexual maturation (puberty) ameliorates the development of 395 lung inflammation in mice. This protective effect of 'puberty' appears to be dependent on estrogen 396 and may be induced by production of the anti-inflammatory mediator SLPI and thereby inhibition of 397 production of pro-inflammatory IL- 33 
